| Market Capitalization (Millions $) |
110,142 |
| Shares
Outstanding (Millions) |
261 |
| Employees |
5,400 |
| Revenues (TTM) (Millions $) |
10,626 |
| Net Income (TTM) (Millions $) |
-480 |
| Cash Flow (TTM) (Millions $) |
-5,869 |
| Capital Exp. (TTM) (Millions $) |
321 |
Vertex Pharmaceuticals Inc
Company Profile: Vertex Pharmaceuticals Inc.
Company Overview
Vertex Pharmaceuticals Inc. is a leading biotechnology company committed to discovering, developing, and commercializing innovative medicines targeting serious diseases. Founded in 1989 and headquartered in Boston, Massachusetts, Vertex has established itself as a pioneer in the field of cystic fibrosis and is expanding its reach into other therapeutic areas.
Specialization in Cystic Fibrosis
Vertex Pharmaceuticals has made a significant impact in the treatment of cystic fibrosis, a genetic disorder that primarily affects the lungs and digestive system. The companys first breakthrough drug, Kalydeco (ivacaftor), received approval in 2012 and is recognized as the first medication that addresses the underlying cause of cystic fibrosis by targeting specific genetic mutations. Following this, Vertex launched additional therapies, including Orkambi (lumacaftor/ivacaftor) and Symdeko (tezacaftor/ivacaftor), which have transformed the lives of many patients living with this condition.
Broader Therapeutic Focus
In addition to its advancements in cystic fibrosis treatments, Vertex Pharmaceuticals is actively exploring other therapeutic domains, including sickle cell disease, beta thalassemia, and pain management. The companys research and development initiatives are primarily centered around small molecules and gene therapies, focusing on the development of precision medicines that aim to directly target the root causes of diseases.
Commitment to Corporate Social Responsibility
Vertex is not only dedicated to medical innovation but also prioritizes corporate social responsibility. The company emphasizes environmental sustainability by implementing practices such as energy conservation, recycling, and sustainable building initiatives to minimize its carbon footprint. Furthermore, Vertex supports patient advocacy organizations and has established various programs designed to enhance patient access to its medications.
Conclusion
Vertex Pharmaceuticals Inc. stands at the forefront of biotechnology, driven by its innovative research, a talented team of scientists and clinicians, and a robust commitment to patients and the community. With its unwavering focus on developing groundbreaking therapies for serious diseases, Vertex is well-positioned to continue making a profound impact in the healthcare landscape.
Company Address: 50 Northern Avenue Boston 2210 MA
Company Phone Number: 341-6100 Stock Exchange / Ticker: NASDAQ VRTX
|
0.26% 
61.82 %